These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3876523)

  • 21. Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse.
    Perry TL; Yong VW; Wall RA; Jones K
    Neurosci Lett; 1986 Sep; 69(3):285-9. PubMed ID: 3489912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity.
    Heikkila RE; Hess A; Duvoisin RC
    Life Sci; 1985 Jan; 36(3):231-6. PubMed ID: 3917525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent depletion of striatal dopamine and its metabolites in mice by TMMP, an analogue of MPTP.
    Fuller RW; Hemrick-Luecke SK
    J Pharm Pharmacol; 1987 Aug; 39(8):667-9. PubMed ID: 2888865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects locomotor activity without producing a nigrostriatal lesion in the rat.
    Sahgal A; Andrews JS; Biggins JA; Candy JM; Edwardson JA; Keith AB; Turner JD; Wright C
    Neurosci Lett; 1984 Jul; 48(2):179-84. PubMed ID: 6333003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources.
    Heikkila RE
    Eur J Pharmacol; 1985 Oct; 117(1):131-3. PubMed ID: 3878793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different toxicity of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) on the nigrostriatal and mesolimbic pathways.
    Ambrosio S; Gerli P; Perego C; Algeri S
    Eur J Pharmacol; 1987 Jan; 133(2):239-41. PubMed ID: 2880741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M; Mariani AP; Neff NH
    Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracerebral MPTP injections in the rat cause cell loss in the substantia nigra, ventral tegmental area and dorsal raphe.
    Takada M; Li ZK; Hattori T
    Neurosci Lett; 1987 Jul; 78(2):145-50. PubMed ID: 3498132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MPTP alters central catecholamine neurons in addition to the nigrostriatal system.
    Gupta M; Felten DL; Gash DM
    Brain Res Bull; 1984 Dec; 13(6):737-42. PubMed ID: 6335836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on presynaptic dopamine uptake sites in the mouse striatum.
    Donnan GA; Kaczmarczyk SJ; Rowe PJ; Figdor R; Mendelsohn FA
    J Neurol Sci; 1986 Jun; 74(1):111-9. PubMed ID: 3487620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
    Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoradiography of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): uptake in the monoaminergic pathways and in melanin containing tissues.
    Lydén A; Bondesson U; Larsson BS; Lindquist NG; Olsson LI
    Acta Pharmacol Toxicol (Copenh); 1985 Aug; 57(2):130-5. PubMed ID: 3877403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective recovery of striatal 125I-alpha-conotoxinmii nicotinic receptors after nigrostriatal damage in monkeys.
    Lai A; Sum J; Fan H; McIntosh JM; Quik M
    Neuroscience; 2004; 127(2):399-408. PubMed ID: 15262330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
    Mayer RA; Kindt MV; Heikkila RE
    J Neurochem; 1986 Oct; 47(4):1073-9. PubMed ID: 3489072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
    Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM
    Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice.
    Heikkila RE; Cabbat FS; Manzino L; Duvoisin RC
    Neuropharmacology; 1984 Jun; 23(6):711-3. PubMed ID: 6611514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of MPTP on uridine uptake in murine nerve cells.
    Pakkenberg H; Pakkenberg B; Fog R; Eldrup E
    Brain Res; 1988 Sep; 460(1):146-9. PubMed ID: 2464401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.